Patents Assigned to Novartis AG (formerly Sandoz Ltd.)
  • Patent number: 6300362
    Abstract: The invention relates to the use of certain acid donors as stabilizers in pharmaceutical compositions, and to the stabilized pharmaceutical compositions resulting therefrom.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: October 9, 2001
    Assignee: Novartis AG (formerly Sandoz Ltd.)
    Inventors: Richard V. Vivilecchia, Bruce A. Ross
  • Patent number: 5650134
    Abstract: Somatostatin peptides bearing a chelating group selected from a bifunctional N.sub.4 -chelating group particularly suitable for Tc, Rh, Cu, Co or Re-labelling, and a bifunctional polyamino-polycarboxylic acid chelating group are complexed with a .alpha.-, .beta.-, .gamma.- or positron-emitting nuclide or a nuclide with Auger-e.sup.- -cascades and are useful as radiopharmaceuticals.
    Type: Grant
    Filed: July 12, 1995
    Date of Patent: July 22, 1997
    Assignee: Novartis AG (formerly Sandoz Ltd.)
    Inventors: Rainer Albert, Helmut Macke